All News #Library
Biotech
Alloy Speeds Complex Fibrosis Targets Toward Clinical Trials
03 Feb 2026 //
PHARMIWEB
Mediar Therapeutics Secures $76M Series B Funding
07 Jan 2026 //
PR NEWSWIRE
Mediar, Lilly License Antibody for Idiopathic Pulmonary Fibrosis
10 Jan 2025 //
PR NEWSWIRE
Mediar Therapeutics Initiates Second Clinical Program
07 Aug 2024 //
PR NEWSWIRE
Mediar Therapeutics Announces Clinical Candidates for Lead Fibrosis Programs
25 Oct 2023 //
PR NEWSWIRE
Mediar gets a spark from Pfizer’s Ignite program
25 Oct 2023 //
FIERCE BIOTECH

Market Place
Sourcing Support